Category: Drug therapies

All Podcast Categories
S4-39 - The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)

S4-39 – The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)

Surfing NASH returns to its regular program with a fresh episode and some fascinating and progressive ideas on non-invasive testing with Mazen Noureddin. For this feature, Mazen talks about his recent work in serum identification of at-risk MASH and the Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF). The Surfers (Jörn Schattenberg, Louise Campbell and Roger Green) respond with their thoughts and varying perspectives.

August 30, 2023
S4-37 - Focus on the Role of Allied Health and Strengthening NASH Education

S4-37 – Focus on the Role of Allied Health and Strengthening NASH Education

This week, Surfing NASH looks back at a Season 3 episode that remains particularly relevant in light of recent stories on new nomenclature and therapeutic developments for liver disease. An all-star panel of liver nurses and advanced nurse practitioners join Louise Campbell and Stephen Harrison to explore the myriad ways allied health experts can play a broader role in NASH education and patient management.

August 16, 2023
S4-36.5 - LOCATE-NAFLD: What’s Next and Practical Takeaways

S4-36.5 – LOCATE-NAFLD: What’s Next and Practical Takeaways

New guest, Prof. James O’Breine, joins Naim Alkhouri, Louise Campbell and Roger Green to discuss improving models for patient identification and risk stratification with the LOCATE-NAFLD project. This final conversation addresses the importance of adequate training in order to optimize the potential of advancing technologies. For final questions, James shares what’s next for the project and the other panelists discuss takeaways from this discussion in terms of improving screening or cost effectiveness.

August 13, 2023
S4-36.4 - LOCATE-NAFLD: Funding and Generating Data

S4-36.4 – LOCATE-NAFLD: Funding and Generating Data

New guest, Prof. James O’Breine, joins Naim Alkhouri, Louise Campbell and Roger Green to discuss improving models for patient identification and risk stratification with the LOCATE-NAFLD project. This conversation focuses on questions around funding before moving on to consider the importance of generating and managing the best sets of data. As the conversation concludes, the group discusses concerns over consistency of scan reads and shares tips on how to get a more accurate measurement.

August 13, 2023
S4-36.3 - LOCATE-NAFLD: Cost Effectiveness and Implementation in Different Systems

S4-36.3 – LOCATE-NAFLD: Cost Effectiveness and Implementation in Different Systems

New guest, Prof. James O’Breine, joins Naim Alkhouri, Louise Campbell and Roger Green to discuss improving models for patient identification and risk stratification with the LOCATE-NAFLD project. This conversation focuses on details of the study design related to cost effectiveness, scalability and feasibility when looking to implement in other countries.

August 12, 2023
S4-36.2 - LOCATE-NAFLD: Study Design and Early Analysis

S4-36.2 – LOCATE-NAFLD: Study Design and Early Analysis

New guest, Prof. James O’Breine, joins Naim Alkhouri, Louise Campbell and Roger Green to discuss improving models for patient identification and risk stratification with the LOCATE-NAFLD project. This conversation features general comments and questions around the study design before James shares two interesting pieces of data from early analysis.

August 12, 2023

Listen Now

Apple Spotify Youtube
Copyright © SurfingNASH.Com 2020—2023
Linkedin Facebook Twitter Instagram
Stay In Touch
Apple Spotify Youtube